| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |